First Eagle Investment Management, LLC, a registered investment adviser, initiated a new position in Elevance Health Inc. (NYSE:ELV) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 3,963,023 shares of the Healthcare company, valued at approximately $1.4B as of the filing date.
Elevance Health Inc.'s stock currently trades at $330.70 with a market capitalization of $80.0B.
